Skip to content

Midmark IQvitals Zone w/Masimo SPO2

by Midmark Corporation

Midmark IQvitals Zone w/Masimo SPO2 (1-200-0330) is a general-purpose multi-parameter bedside monitor (FDA Class II) made by Midmark Corporation, cleared under FDA 510(k) K161909 on 17 Nov 2016 and listed in FDA GUDID since 7 Apr 2017 (UDI-DI 00841709105807), active as of 22 Oct 2026. 4 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

4 ongoing

This device is named in the recall

Documents

510(k) K161909

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00841709105807 UDI-DI Date7 Apr 2017ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK161909 Date17 Nov 2016DecidedStatusActive

Official records

From the FDA record

Device description
IQvitals Zone, non-Wireless, with Serenity BP, Exergen TemporalScanner and Masimo SpO2
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K161909 decided 17 Nov 2016 Active
  • FDA GUDID UDI-DI 00841709105807 listed 7 Apr 2017 Listed

Recalls

4 recalls · 4 ongoing · FDA

  • 4 recalls, same reason

    • Ongoing Z-3218-2026 FDA Class II initiated 21 Aug 2026
    • Ongoing Z-3219-2026 FDA Class II initiated 21 Aug 2026
    • Ongoing Z-3217-2026 FDA Class II initiated 21 Aug 2026
    • Ongoing Z-3220-2026 FDA Class II initiated 21 Aug 2026

    A performance issue may result in inaccurate blood pressure readings when the Linear Deflation Method is used.

Timeline

6 dated events

  1. Cleared FDA 510(k) K161909
  2. Listed FDA GUDID 00841709105807
  3. Recall initiated FDA recalls Z-3218-2026
  4. Recall initiated FDA recalls Z-3219-2026
  5. Recall initiated FDA recalls Z-3217-2026
  6. Recall initiated FDA recalls Z-3220-2026

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Midmark
Generic name
General-purpose multi-parameter bedside monitor
Model / Ref / Catalog
IQvitals Zone w/Masimo SPO2, 1-200-0330
Primary DI / UDI-DI
00841709105807
510(k) Number
FDA product code
MWI, FLL, DQA, DXN
GMDN term
General-purpose multi-parameter bedside monitor
Device class
Class II
Regulation number
870.2300, 880.2910, 870.2700, 870.1130
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under General-purpose multi-parameter bedside monitor.

Other devices from Midmark Corporation

  • Midmark 1-300-0200

    Class II
  • Midmark 1-300-0100

    Class II
  • Midmark 1-300-0400

    Class II
  • Midmark 1-300-0300

    Class II

See all devices from Midmark Corporation →

Properties

  • Prescription use
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)